Clinical Thiazolidinediones as PPAR&ggr; Ligands with the Potential for the Prevention of Cardiovascular Disease in Diabetes

Publisher： Bentham Science Publishers

E-ISSN： 1875-6417|2|2|227-239

ISSN： 1573-3998

Source： Current Diabetes Reviews, Vol.2, Iss.2, 2006-05, pp. : 227-239

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

PPAR&ggr; Agonists: Beneficial Effect on Blood Pressure Beyond Glycemic Control?

By  

Current Hypertension Reviews, Vol. 2, Iss. 1, 2006-02 ,pp. : 47-60

Bentham Science Publishers

Access to resources Recommend Favorite

Crucial Role of Interferon-&ggr; and Stimulated Macrophages in Cardiovascular Disease

By  

Current Vascular Pharmacology, Vol. 4, Iss. 3, 2006-07 ,pp. : 205-213

Bentham Science Publishers

Access to resources Recommend Favorite

Role of Prostaglandin (PG) and Peroxisome Proliferator-Activated Gamma (PPAR &ggr; ) in Pulmonary Fibrosis

By  

Current Respiratory Medicine Reviews, Vol. 5, Iss. 1, 2009-02 ,pp. : 3-5

Bentham Science Publishers

Access to resources Recommend Favorite

Diabetes mellitus and cardiovascular disease

By Wagner A.M.   Martnez-Rubio A.   Ordonez-Llanos J.   Perez-Perez A.  

European Journal of Internal Medicine, Vol. 13, Iss. 1, 2002-02 ,pp. : 15-30

Elsevier

Access to resources Recommend Favorite

PPAR- &ggr; Agonist in Treatment of Diabetes: Cardiovascular Safety Considerations

By  

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol. 10, Iss. 2, 2012-06 ,pp. : 124-134

Bentham Science Publishers

Access to resources Recommend Favorite